Bisphosphonate Inhibition of bone resorption induced by particulate biomaterial-associated macrophages
Open Access
- 1 January 1996
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 67 (3) , 221-228
- https://doi.org/10.3109/17453679608994677
Abstract
Aseptic loosening of total joint replacements is associated with bone resorption. A heavy infiltrate of foreign body macrophages in response to biomateri-al wear particles is commonly found in the fibrous membrane surrounding loose components. It has recently been shown that foreign body macrophages can differentiate into osteoclastic cells. To determine whether pharmacological inhibitors of bone resorption have a role to play in controlling the osteolysis of aseptic loosening, we analyzed the effect of a bisphosphonate, disodium ethane-1, 1-diphos-phonate (EHDP) on this process. Murine monocytes and foreign body macrophages (derived from granulomas formed by subcutaneous implantation of particles of prosthetic biomaterials) were co-cultured with UMR106 osteoblast-like cells in the presence of 1, 25 dihydroxyvitamin D3 for 14 days on glass cover-slips and bone slices. EHDP significantly inhibited bone resorption in these co-cultures. There was little or no expression of the osteoclast-associated enzyme, tartrate-resistant acid phosphatase (TRAP) in EHDP-treated co-cultures. Addition of EHDP to monocyte-UMR106 co-cultures after the appearance of TRAP-positive cells did not abolish bone resorption, indicating that EHDP, in addition to its known inhibitory effect on osteoclast function, suppresses differentiation of osteoclast precursors. EHDP inhibition of the osteolysis induced by particulate biomaterial-associated macrophages shows that pharmacological inhibition of bone resorption might be used to control the osteolysis of aseptic loosening.Keywords
This publication has 33 references indexed in Scilit:
- Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors.Journal of Clinical Investigation, 1993
- Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineageJournal of Bone and Mineral Research, 1990
- Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.Journal of Clinical Investigation, 1990
- Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: The effect of a bisphosphonateJournal of Bone and Mineral Research, 1988
- Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophagesJournal of Bone and Mineral Research, 1987
- Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast functionCalcified Tissue International, 1982
- Differential Action of the Bisphosphonates (3-Amino-1-Hydroxypropylidene)-1,1-Bisphosphonate (APD) and Disodium Dichloromethylidene Bisphosphonate (Cl2MDP) on Rat Macrophage-mediated Bone Resorption In VitroJournal of Clinical Investigation, 1982
- F4/80, a monoclonal antibody directed specifically against the mouse macrophageEuropean Journal of Immunology, 1981
- Diphosphonates inhibit bone resorption by macrophages in vitroThe Journal of Pathology, 1980
- The cellular evolution of inflammatory granulomataThe Journal of Pathology and Bacteriology, 1966